Beijing Tong Ren Tang Chinese Medicine Company Limited
BJTRF
$0.5645
-$0.7413-56.77%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 60.91M | 60.72M | 42.50M | 42.49M | 45.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.91M | 60.72M | 42.50M | 42.49M | 45.57M |
| Cost of Revenue | 21.45M | 21.38M | 13.61M | 13.60M | 11.00M |
| Gross Profit | 39.46M | 39.34M | 28.89M | 28.88M | 34.57M |
| SG&A Expenses | 19.11M | 19.05M | 12.59M | 12.58M | 16.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 78.70K | 78.50K | -249.40K | -249.30K | -332.80K |
| Total Operating Expenses | 40.64M | 40.51M | 25.94M | 25.93M | 26.76M |
| Operating Income | 20.27M | 20.21M | 16.56M | 16.55M | 18.80M |
| Income Before Tax | 22.26M | 22.19M | 18.14M | 18.13M | 21.36M |
| Income Tax Expenses | 3.69M | 3.67M | 2.77M | 2.77M | 2.63M |
| Earnings from Continuing Operations | 18.58M | 18.52M | 15.37M | 15.37M | 18.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -535.50K | -533.80K | -1.32M | -1.31M | -1.18M |
| Net Income | 18.04M | 17.98M | 14.06M | 14.05M | 17.55M |
| EBIT | 20.27M | 20.21M | 16.56M | 16.55M | 18.80M |
| EBITDA | 20.88M | 20.82M | 17.15M | 17.15M | 19.29M |
| EPS Basic | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 837.10M | 837.10M | 837.10M | 837.10M | 837.10M |
| Average Diluted Shares Outstanding | 837.10M | 837.10M | 837.10M | 837.10M | 837.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | 0.00% | 125.69% | 125.69% | 0.00% |